Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging

被引：34
|
作者：
Steinert, HC [1 ]
Dellea, MMS
Burger, C
Stahel, R
机构：
[1] Univ Zurich Hosp, Dept Med Radiol, Div Nucl Med, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Div Oncol, CH-8091 Zurich, Switzerland
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/j.lungcan.2005.03.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S33 / S35
页数：3
相关论文
共 50 条
  • [21] FDG PET/CT RESPONSE EVALUATION IN MALIGNANT PLEURAL MESOTHELIOMA PATIENTS TREATED WITH TALC PLEURODESIS AND CHEMOTHERAPY
    Genestreti, Giovenzio
    Moretti, Andrea
    Piciucchi, Sara
    Giovannini, Noemi
    Milandri, Carlo
    Marzullo, Anna Maria
    Scarpi, Emanuela
    Santo, A.
    Poletti, Venerino
    Matteucci, Federica
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1354 - S1354
  • [22] PET/CT and Postoperative Surveillance in Malignant Pleural Mesothelioma
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (02) : 18N - 18N
  • [23] FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and Chemotherapy
    Genestreti, Giovenzio
    Moretti, Andrea
    Piciucchi, Sara
    Giovannini, Noemi
    Galassi, Riccardo
    Scarpi, Emanuela
    Burgio, Marco Angelo
    Amadori, Dino
    Sanna, Stefano
    Poletti, Venerino
    Matteucci, Federica
    Gavelli, Giampaolo
    JOURNAL OF CANCER, 2012, 3 : 241 - 245
  • [24] PET-CT detects response to treatment with ipilimumab and nivolumab in malignant mesothelioma better than CT
    Christoph, Daniel
    Metzenmacher, Martin
    Boeluekbas, Servet
    Volmerig, Jan
    Nilius, Georg
    Moka, Detlef
    Hautzel, Hubertus
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 218 - 218
  • [25] Malignant Pleural Mesothelioma: Role of CT, MRI, and PET/CT in Staging Evaluation and Treatment Considerations
    Truong, Mylene T.
    Viswanathan, Chitra
    Godoy, Myrna B. C.
    Carter, Brett W.
    Marom, Edith M.
    SEMINARS IN ROENTGENOLOGY, 2013, 48 (04) : 323 - 334
  • [26] REAL WORLD EXPERIENCE OF THE USE OF PET-CT FOR DISTINGUISHING BETWEEN BENIGN PLEURAL DISEASE AND MALIGNANT MESOTHELIOMA
    Prior, K.
    Fingleton, J.
    Howell, T.
    THORAX, 2014, 69 : A24 - A25
  • [27] Pleural malignant mesothelioma (MM). Imaging evaluation
    Zompatori, M
    2ND INTERNATIONAL CONGRESS OF THORAX SURGERY, 1998, : 33 - 34
  • [28] THE ROLE OF 18F-FDG PET-CT IN DIAGNOSIS AND PREDICTION OF PROGNOSIS IN MALIGNANT PLEURAL MESOTHELIOMA
    Simsek, Duygu Has
    Kuyumcu, Serkan
    Sanli, Yasemin
    Ozkan, Zeynep Gozde
    Ozkan, Berker
    Turkmen, Coneyt
    Yilmazbayhan, Emine Dilek
    Mudun, Ayse
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2019, 82 (04): : 168 - 173
  • [29] Relationship between 18 FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma
    Abakay, A.
    Komek, H.
    Abakay, O.
    Palanci, Y.
    Ekici, F.
    Tekbas, G.
    Tanrikulu, A. C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (09) : 1233 - 1241
  • [30] Staging and response to therapy of malignant pleural mesothelioma
    Heelan, R
    LUNG CANCER, 2004, 45 : S59 - S61
12345